[MO23] Mini-Oral Session 23　肝胆膵4（胆嚢・胆道 その他）
【E】

[MO23-2] Characteristics, treatment patterns, and healthcare costs of advanced/metastatic biliary tract cancer patients in Japan

^○Seok-Won Kim¹, Xin Wang², Chi-Chang Chen², Shingo Wada¹, Jamie Garside³, Emily S. Reese⁴ (1.IQVIA, Tokyo, Japan, 2.IQVIA, Plymouth Meeting, PA, USA, 3.GlaxoSmithKline, London, UK, 4.EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA)